About
Michael first joined Abbott in 1993. He joined AbbVie in 2013. At AbbVie he was Chief Financial Officer from 2018, Vice Chairman and President from 2022, and President and Chief Operating Officer from 2023, before becoming CEO. Other pharmaceutical company chief executives on Whoo include David Ricks of Eli Lilly and Robert Bradway of Amgen.
Whoo compiled this page from public sources: AbbVie 2026 proxy statement (SEC), AbbVie press release, July 2024 (PR Newswire), Medical Dialogues, February 2025, AbbVie 2025 annual report (SEC). It is not affiliated with or endorsed by Robert Michael. Are you Robert Michael? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.
Want a page like this? Create yours from your résumé.
Experience
Chairman and Chief Executive Officer — AbbVie
2024 – Present
- Became CEO in July 2024 and chairman in July 2025
- Oversaw commercial operations, finance, human resources, operations, business development and strategy
- Held leadership roles across several business units before moving to AbbVie in 2013
President and Chief Operating Officer — AbbVie
2023 – 2024
Vice Chairman and President — AbbVie
2022 – 2023
Vice Chairman, Finance and Commercial Operations, and Chief Financial Officer — AbbVie
2021 – 2022
Executive Vice President and Chief Financial Officer — AbbVie
2019 – 2021
Senior Vice President and Chief Financial Officer — AbbVie
2018 – 2019
Leadership roles in several business units — Abbott
1993 – 2013
Education
Education
Not published in sources